Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Comments

Loading...

Innovent Biologics Stock News

IVBIYOTCPK

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$19.15

At close: Nov 21, 11:58 AM EDT

Innovent Biologics (IVBIY) Forecast

News

Earnings Innovent Biologics (IVBIY) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Innovent Biologics Stock News | OTC:IVBIY | Benzinga

Get the latest news on Innovent Biologics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Innovent Biologics performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Monday, February 24, 2025

Reported Sunday, Innovent's Ipilimumab Inject...
Benzinga Newsdesk

Friday, January 17, 2025

Reported Earlier, Innovent And ASK Pharm Anno...
Benzinga Newsdesk

Thursday, January 16, 2025

Reported Earlier, Innovent's IBI343 Receives ...
Benzinga Newsdesk

Thursday, January 02, 2025

Reported Wednesday, Roche And Innovent Forge ...
Benzinga Newsdesk

Monday, December 16, 2024

Reported Earlier, Innovent And Lilly Expand G...
Benzinga Newsdesk

Thursday, September 26, 2024

Innovent's Psoriasis Drug Picankibart Shows R...
Benzinga Newsdesk

Wednesday, September 18, 2024

Reported Earlier, Innovent Presents Phase 1 C...
Benzinga Newsdesk

Thursday, September 12, 2024

Reported Earlier, Innovent's Phase 3 DREAMS-2...
Benzinga Newsdesk

Tuesday, September 10, 2024

Reported Earlier, Innovent Presents Update On...
Benzinga Newsdesk

Wednesday, September 04, 2024

Reported Earlier, Innovent Receives FDA Fast ...
Benzinga Newsdesk

Tuesday, April 02, 2024

HUTCHMED And Innovent Announce NDA Acceptance...
Benzinga Newsdesk

Wednesday, March 27, 2024

Reported Earlier, Innovent Dosed First Partic...
Benzinga Newsdesk

Tuesday, March 05, 2024

Innovent And AnHeart Therapeutics Announce Th...
Benzinga Newsdesk

Friday, March 01, 2024

Innovent Announces First Participant Dosed In...
Benzinga Newsdesk

Thursday, December 28, 2023

Innovent And Xuanzhu Collaborate On A Clinica...
Benzinga Newsdesk

Monday, December 18, 2023

Innovent Biologics Publishes Mazdutide (IBI36...
Benzinga Newsdesk

Thursday, March 24, 2022

FDA Rejects Lilly's Sintilimab/Chemo Combo Therapy In First-Line Lung Cancer Setting
Vandana Singh

Friday, February 11, 2022

FDA AdComm Votes Against Lilly's Lung Cancer Drug, Sintilimab
Vandana Singh

Tuesday, September 28, 2021

Innovent Biologics, UNION therapeutics Ink Licensing Pact For Inflammatory Dermatology Candidate
Vandana Singh

Friday, August 27, 2021

Innovent Biologics, Bolt Join Forces To Develop Anti-Cancer Candidates
Vandana Singh

Monday, August 16, 2021

Innovent's Sintilimab/Chemo Regime Shows Overall Survival Benefit In Gastric Cancer
Vandana Singh

Friday, August 06, 2021

Innovent - Eli Lilly's Sintilimab Combo Shows Sustained Survival Benefit In Lung Cancer Patients
Vandana Singh

Friday, July 09, 2021

Innovent Biologics - Incyte's Pemigatinib Application Under Review In China For Bile Duct Cancer
Vandana Singh

Thursday, June 03, 2021

Eli Lilly-Innovent Biologics Score Expanded Use Approval of Tyvyt n Lung Cancer Patients In China
Vandana Singh

Tuesday, May 18, 2021

Lilly-Innovent's Sintilimab Plus Chemo Application For Lung Cancer Under Review With FDA
Vandana Singh

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved